ENG/中
老虎證券
行情
交易
收費
下載
優惠與活動
幫助
TigerAI
學堂
期權訓練營
投資學堂
機構
財富及資產管理人
自營交易機構
介紹經紀商
三方服務商
股權激勵
關於
關於我們
媒體報道
獎項與榮譽
登入
立即註冊
Toggle
美股
詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務
Defiance Daily Target 2X Long MRNA ETF
81.41
+7.57
10.25%
盤後:
82.00
0.5900
+0.72%
19:51 EDT
成交量:
25.97萬
成交額:
2,154.65萬
市值:
2,605.12萬
市盈率:
- -
高:
87.50
開:
74.73
低:
72.45
收:
73.84
52周最高:
143.84
52周最低:
14.95
股本:
32.00萬
流通股本:
32.00萬
量比:
1.11
換手率:
81.17%
股息:
- -
股息率:
- -
淨資產收益率:
--
總資產收益率:
--
市淨率:
--
市盈率(LYR):
- -
資料載入中...
總覽
公司
新聞
公告
概念
沒有相關數據
資金流向
資金流入:
資金流出:
實時
日
周
月
季度
年
新聞
阿斯利康股價盤後跌超2%,因其三期臨床試驗結果令人失望。
智通财经
·
昨天
Moderna Inc(MRNA)股票9月11日盤中上漲8.63%:關鍵驅動因素揭曉
TradingKey中文
·
昨天
沃森生物(300142.SZ)子公司新型冠狀病毒mRNA疫苗獲得藥品註冊證書
智通财经
·
09/10
沃森生物:玉溪沃森mRNA疫苗獲批上市許可,適用18周歲以上
智通财经
·
09/10
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎證券香港 | 輕鬆買賣美股港股A股/美債/ETF/Crypto/期權期貨","description":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投,即時串流報價與多種工具,立即開戶享更多優惠!","keywords":"老虎證券,老虎證券開戶,老虎證券香港,老虎證券投資,老虎證券美股,老虎證券登錄,證券開戶,證券公司開戶,股票開戶,香港證券公司,香港證券,證券公司,美股投資平台,小額投資理財,投資app,投資平台,股票買賣,買賣股票平台,炒股app,證券app,新手投資","social":{"ogDescription":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投,即時串流報價與多種工具,立即開戶享更多優惠!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrcrest.com/hant/stock/MRNX"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"MRNX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MRNX\",,,,,undefined,":{"symbol":"MRNX","market":"US","secType":"STK","nameCN":"Defiance Daily Target 2X Long MRNA ETF","latestPrice":81.41,"timestamp":1789156800000,"preClose":73.84,"halted":0,"volume":259735,"hourTrading":{"tag":"盘后","latestPrice":82,"preClose":81.41,"latestTime":"19:51 EDT","volume":2532,"amount":208418.93,"timestamp":1789170707443,"change":0.59,"changeRate":0.007247,"amplitude":0.017074},"delay":0,"changeRate":0.10251895991332602,"floatShares":320000,"shares":320000,"eps":0,"marketStatus":"休市中","change":7.57,"latestTime":"09-11 16:00:00 EDT","open":74.73,"high":87.5,"low":72.45,"amount":21546481.856725,"amplitude":0.203819,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":2,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1789372800000},"marketStatusCode":7,"adr":0,"exchange":"ARCA","adjPreClose":73.84,"sharesOutstanding":30000,"nav":73.79,"aum":23612800,"bidAskSpread":0,"preHourTrading":{"tag":"盘前","latestPrice":74.76,"preClose":73.84,"latestTime":"09:29 EDT","volume":2911,"amount":214048.38003600002,"timestamp":1789133357153,"change":0.92,"changeRate":0.012459,"amplitude":0.04117},"postHourTrading":{"tag":"盘后","latestPrice":82,"preClose":81.41,"latestTime":"19:51 EDT","volume":2532,"amount":208418.93,"timestamp":1789170707443,"change":0.59,"changeRate":0.007247,"amplitude":0.017074},"volumeRatio":1.1097585784501116,"impliedVol":1.2558,"impliedVolPercentile":0.0833},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MRNX\",,,,,undefined,":{"symbol":"MRNX","floatShares":320000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":1.1097585784501116,"shares":320000,"dividePrice":0,"high":87.5,"amplitude":0.203819,"preClose":73.84,"low":72.45,"week52Low":14.95,"pbRate":"--","week52High":143.84,"institutionHeld":0,"latestPrice":81.41,"eps":0,"divideRate":0,"volume":259735,"delay":0,"ttmEps":0,"open":74.73,"prevYearClose":20.61,"prevWeekClose":84.15,"prevMonthClose":79.5,"prevQuarterClose":42.65,"fiveDayClose":88.29,"twentyDayClose":31.9518,"sixtyDayClose":28.6713},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/MRNX\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"MRNX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"MRNX\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"MRNX\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2666571008","title":"阿斯利康股價盤後跌超2%,因其三期臨床試驗結果令人失望。","url":"https://stock-news.laohu8.com/highlight/detail?id=2666571008","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666571008?lang=zh_tw&edition=fundamental","pubTime":"2026-09-12 04:23","pubTimestamp":1789158183,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU2322448957.HKD","IBB","MRNY","PSCH","PJP","IYH","BK4588","FTXH","IDNA","LU1992135399.USD","FBT","TMED","IEIH","LU2272731600.USD","RXL","SYNB","WDNA","LU2272731865.HKD","RSPH","IBRN","SBIO","LFSC","LU1992135472.HKD","BK4585","LU2322448791.USD","BIB","BIOY","HELX","AZNH","CANC","LU2473716301.USD","IEHS","XBIX","PPH","MEDI","XPH","IE00B5TLWC47.USD","GNOM","BBP","MRNX","BME","LU2272731782.SGD","PBPH","PBE","BBH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666657657","title":"Moderna Inc(MRNA)股票9月11日盤中上漲8.63%:關鍵驅動因素揭曉","url":"https://stock-news.laohu8.com/highlight/detail?id=2666657657","media":"TradingKey中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666657657?lang=zh_tw&edition=fundamental","pubTime":"2026-09-12 01:16","pubTimestamp":1789146984,"startTime":"0","endTime":"0","summary":"• 受机构买盘重新涌入及盘整巩固的推动,莫德纳出现上行波动。\n• intismeran autogene 的 3 期临床试验结果验证了其肿瘤学平台。\n• 最新年度营收为 19.4 亿美元,净亏损为 28.2 亿美元。","market":"fut","thumbnail":"https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/zh-hans/news/market-movers/262164048-market-movers-mrna-20260911","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MRNA","BK4501","GNOM","LGHT","BK4548","BK4568","WDNA","BK4533","BK4139","MRNX","IDNA","BK4532","BK4534","MRNY","BK4551","BK4585","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666596397","title":"沃森生物(300142.SZ)子公司新型冠狀病毒mRNA疫苗獲得藥品註冊證書","url":"https://stock-news.laohu8.com/highlight/detail?id=2666596397","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666596397?lang=zh_tw&edition=fundamental","pubTime":"2026-09-10 20:57","pubTimestamp":1789045066,"startTime":"0","endTime":"0","summary":"智通财经APP讯,沃森生物 发布公告,公司全资子公司玉溪沃森生物技术有限公司于2026年9月10日收到由国家药品监督管理局批准颁发的“新型冠状病毒mRNA疫苗”《药品注册证书》。据悉,该疫苗是公司基于mRNA平台技术策略迭代开发的第三代新冠病毒mRNA疫苗。目前,mRNA技术在全球正应用于生物医药前沿科技创新研发及应用领域。自2020年以来,公司对mRNA技术持续加大研发投入,建立了国内领先的mRNA技术和产业化平台。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1494658.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0239","MRNY","300142","BK0046","MRNX","BK0070","BK0077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666989385","title":"沃森生物:玉溪沃森mRNA疫苗獲批上市許可,適用18周歲以上","url":"https://stock-news.laohu8.com/highlight/detail?id=2666989385","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666989385?lang=zh_tw&edition=fundamental","pubTime":"2026-09-10 19:48","pubTimestamp":1789040889,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["MRNX","IPOS","MRNY"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":50,"pageCount":1,"totalSize":200,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/MRNX\",params:#limit:6,delay:false,,,undefined,":[]}}